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2 Evaluation of the Second Action Plan of the 
"Europe against Cancer" Programme, 1990- 1994, plus 1995. 
1.  INTRODUCTION 
1.1.  The objectives of this evaluation were to  measure  the  extent to  which  the 
specific  objectives  of the  Second  Action  Plan  of the  « Europe  Against 
Cancer » Programme (EAC)  have  been  achieved,  and  to  identify  how the 
EAC programme had functioned, in what context it had operated across and 
within countries, and which factors had facilitated and hampered the efficient 
and effective implementation ofthe programme. 
1.2.  The  evaluation is  the  result of a call  for  tender launched  by  the  European 
Commission  in  1996.  The  contract  was  awarded  to  the  Association  of 
Schools of Public Health in the European Union (ASPHER) in collaboration 
with the European Public Health Association (EUPHA) and together with the 
Royal  College  of Physicians  (RCP)  and  a  representative  of the  Finnish 
Ministry of Health (FMoH) (as Finland was among the three Member States 
not yet significantly involved at the time of  the second action plan). 
1.3.  The evaluation was carried out between December 1997 and July 1998. The 
main  report  is  more  than  a  hundred  pages  long  and  the  five  volumes  of 
enclosures  more  than  eight  hundred.  The  following  summary  is  mainly 
focused on the conclusions and recommendations of  the report. 
1.4.  The report is available from the Commission Services. 
2.  CORE OF THE EvALUATION REPORT CARRIED OUT BY ASPHER 
2.1.  Methodology. 
2.1.1.  The Europe Against Cancer Programme (EAC) was launched as an 
initiative  that  would  be  meaningful  to  the  citizens  of Europe  and 
bring them closer to the Community and tackle a major health issue 
2.1.2.  The  EAC  has  certainly achieved a high  profile in  many  Member 
States and has focused attention on cancer as an issue of real public 
concern.  It has  also  sponsored  initiatives  that  cut  across  sectors. 
However,  it  is  less  easy  to  measure  its  impact  on cancer per se, 
particularly  given  the  time  frame  involved  and  the  complexity of 
causal relationships in health issues. 
2.1.3.  In addition, the EAC has not been a single, uniform programme.  It 
has  run ·as  three  successive  action  plans,  the  third  of which  is 
currently underway.  The present report evaluates the second action 
plan  which  covered  the  years  1990-1994 .  and  was  extended  to 
include  the  year  1995.  Since  the  second  action  plan  cannot  be 
viewed in  isolation from  the early years of the  programme (1987-
1989), it has been set in the wider context of  EAC as a whole. 
2.1.4.  The projects supported were divided into eleven domains or fields of 
action,  which  were  further  sub-divided  into  38  targets.  Despite 
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proved sufficiently robust to allow the evaluators involved to review 
activity over the whole period.  These fields of action fit within the 
four key funding categories and were: 
I  ·  Cancer Prevention 
lA  Prevention  of  tobacco  consumption:  including  information 
campaigns targeted at  young people, teachers,  health professionals 
and the workplace 
IB  Diet and cancer: supporting studies of eating habits and cancer, and 
developing nutrition guidelines 
IC  Campaign  against  carcinogenic  agents:  involving  research  and 
actions  on  exposure  to  dioxin,  ultraviolet  radiation  and  other 
carcmogens 
ID  Systematic  screening/early  diagnosis:  supporting  pilot  screening 
projects  for  breast,  cervical  and  colorectal  cancer  and  promoting 
studies on effectiveness of  screening 
IE  Cancer registers:  exchanging experience in registers across Europe 
to foster best practice 
IF  Other:  this  category  featured  support  for  quality  assessment  in 
radiotherapy and chemotherapy, projects on paediatric oncology and 
quality of  palliative care, among other issues. 
II  Health Information and Education 
IIA  Information  of the  public:  featured  the  updating  of the  European 
Code Against Cancer, Europe-wide campaigns and events relating to 
the "Europe against Cancer"Weeks, as well as information aimed at 
the workplace 
liB  Health education and  cancer:  focused  on raising the  awareness of 
schoolteachers,  disseminating  European  teaching  materials  and 
encouraging better diet in schools 
III  Training of  health professionals 
IIIA/B  Training of  doctors & Training of  nurses: these two areas were taken 
together for the purposes of this evaluation and covered the piloting 
of  training schemes in oncology and palliative care and the exchange 
of  experience, best practice and teaching materials 
4 IV.  Research and Cancer 
This heading was used largely to cover several co-ordination activities of  the 
programme. 
2.2.  Results. 
2.2.1.  The recommendations contained in the evaluation report of  the First 
Action Plan have generally been followed,  but the implementation 
may  not  be  as  comprehensive  and  effective  as  the  impression 
conveyed by the Commission's implementation report of 1995. 
2.2.2.  The evaluation focused on what the Programme has funded, i.e. the 
projects. It did not assess the legislative action undertaken in relation 
to some activities, nor the research projects conducted by other DGs 
in relation to the programme. 
2.2.3.  Independent experts with relevant experience undertook the field-of-
action  evaluations  and  similarly  experienced  individuals  were 
appointed to review the programme on a country-by-country basis, 
presenting their  initial  findings  to a  seminar of interested  parties 
before submitting a  final  report.  Members of the core evaluation 
team carried out interviews with the key individuals involved in the 
Commission's central management of  the programme. 
2.2.4.  It has to be underlined that the present evaluation took place several 
years after the completion of a number of the projects and that the 
whole context, political as well as scientific, may in some cases have 
changed. 
2.2.5.  Nevertheless the Second Action Plan has clearly contributed to the 
breaking down of taboos  associated with cancer and has  brought 
particular themes very much to the fore, breast and skin cancer being 
obvious examples. It is also clear that EAC campaigns concerned 
with preventing tobacco consumption, with carcinogenic agents and 
with information for the public and health education all contributed 
to raising the profile of  cancer and prevention activities. 
2.2.6.  However, they were felt to rely too heavily on small initiatives that 
suffered badly from a lack of  solid evidence that might demonstrate 
their effectiveness scientifically. 
2.2.7.  Systematic screening and early detection measures were thought to 
be  more successful, particularly in as much as they were able to 
extend models of best practice, although there were concerns about 
quality and the consistency of the parameters used across Member 
States.  There  was  also  agreement  that  it  was  time  to  rely  more 
heavily  on national  funding  in  the  areas  of breast  and  cervical 
screening  and  to  move  on  to .address  experimental  projects  at  a 
European level that could inform policy on colorectal, prostate and 
skin cancer screening. 
2.2.8.  Cancer registries were also found to have improved over the lifetime 
of  the Second Action Plan but to be ready for a change in emphasis 
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on wider epidemiological research was also raised in this area. 
2.2.9.  Quality Assurance as an area was problematic. Although action has 
been taken in the field of  radiotherapy and chemotherapy, there was 
thought  to  have  been  a  failure  to  address  quality  of life  as 
recommended by the first evaluation. 
2.2.1 0.  The  training  undertaken  was  fragmented  and  overly  focused  on 
particular skills. It failed to address the wider public health agenda 
and reflected a lack of coherence in the field of action as a whole. 
EAC has not succeeded in assisting the process of creating a cadre 
of  cancer prevention specialists in Europe. 
2.2.11.  However, the field evaluators tended to concur that the bulk of the 
projects sponsored, even where the outcomes were debatable, had 
been carried out to the best of the ability of the parties concerned. 
There was very  little sense that there  had  been any abuse of the 
processes  concerned.  There  was  also  an  understanding  that  the 
relatively  small  scale  of the  projects  undertaken  meant that  any 
losses  through  failure  to  deliver  were  also  relatively  small. 
However, there was almost universal concern about the quality of 
reporting,  monitoring  and  record  keeping  by  the  project  leaders 
concerned. 
2.2.12.  All  country  experts  and  many  of the  field  evaluators  also  drew 
attention  to  the  difficulties  created  by  the  administration  of the 
programme.  There  were  profound  concerns  about  the  funding 
process and the mechanisms for longer tenn  funding, breakdowns 
or  gaps  in  reporting  and  the  failure  to  build  in  appropriate 
performance measures. 
2.2.13.  In terms of  the EAC specifically achieving a shift in the patterns and 
reduction in the impact of a major disease group, or more broadly 
mitigating  the  threat  of cancer  to  the  health  status  of the  EU 
population,  it  is  much  more  difficult  to  analyse  and  evaluate. 
Morbidity  and  mortality  associated  with  cancer  are  part  of an 
extremely complex and prolonged context beyond the scope of this 
evaluation.  Clearly it is just not possible to &ttribute  variations in 
morbidity and mortality to the EAC programme; rather, the issue has 
to be viewed in terms of possible/probable influence and what can 
be acceptably measured in the short time frame.  The first evaluation 
report  rightfully  pointed  out  the  usefulness  of  delineating 
intermediate  objectives  that  can  be  more  directly  related  to  the 
actions of  the programme. 
2.2.14.  Thus the state of any cancer prevention programme in Europe is 
necessarily measured by the extent to which contributing factors are 
decreasing  as  a  cause  for  new  cases  rather  than  by  an  actual 
reduction  in deaths:  indeed  any  consequential  decline  would  not 
necessarily occur in the period that followed the programme and its 
evaluation.  There  are  various  estimates  of the  relative  role  of 
different  causal  factors  in  cancer  deaths  in  western,  developed 
6 countries.  However,  it is clear that of total  cancer-related deaths, 
approximately 30% can be attributed to tobacco and 35% to dietary 
factors.  This  illustrates  that  the  major  mechanism  for  reducing 
cancer deaths  is through a  reduction in tobacco  consumption and 
through rather less specific and clear changes in dietary habits. To 
this end the European Code against Cancer sets out a succinct set of 
rules which clearly represent the major essential themes. 
2.3.  Overall recommendations. 
2.3.1.  It  was  therefore  widely  agreed  that  in  order  to  capitalise  on  the 
efforts of the Second Action Plan it will be necessary to  reinforce 
the  most  effective  components  of the  programme,  to  ensure  it 
responds to scientific evidence and  provides for  a systematic  and 
professional  dissemination  of best  practice;  and  to  refocus  the 
management  structures to  make  them  as  efficient  as  possible and 
fully supportive of  project work. 
2.3.2.  The review by experts on a field-by-field basis, in conjunction with 
the country evaluation, suggests the need for there to be key changes 
in the focus of  particular actions. 
2.3.3.  There is a need to review the decision-making and  priority-setting 
agenda and to make the scientific basis of approaches and evidence-
based decisions entirely transparent. 
2.3.4.  There  should  be  a  refocusing  of the  interpretation  of European 
interest and Community added value to ensure that there is a balance 
between  the. need  to  encourage  on  the  one  hand  multi-member 
undertakings and large projects that are able to bring scientific (and 
cultural)  added  value,  and  on  the  other  hand  innovative  small 
projects  that  might  pilot  particular  schemes  and  permit  the 
development of  best practice in the field. 
2.3.5.  There  ought  to  be  a  balance  between  the  inputs  of the  various 
interested parties in the scientific content and their inputs into policy 
or  decision  making  so  that  there  is  scope  for  oncologists  and 
prevention  experts  and  also  for  national  representation  and  due 
process. 
2.3.6.  The  evaluation  concludes  with  this  list  of  38  detailed 
recommendations. 
2.3. 7.  Focus of  the Programme. 
1.  Redefine the parameters of the programme and  institute a 
clear and visible strategic focus on a more limited number  · 
of  process objectives. 
2.  Clarify  European  Added  Value  and  apply  it  more 
effectively. 
J..  Integrate  more  effectively  European  and  national 
prevention priorities. Notably, exploit whatever added joint 
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perceived in Member States associated with the  European 
ideal in the field of  effective cancer prevention. 
4.  Encourage  attempts  to  foster  public  health  policy  and 
document the extent to which EAC  might support projects 
that  challenge  the  policies  of  any  given  national 
government. 
5.  Use informal consultation with a wide group of prominent 
cancer  specialists,  including  a  group  of Public  Health 
experts, to advise on policy at the beginning of  the planning 
phase of  the next five-year programme. 
6.  Produce  a  coherent  and  relatively  homogeneous  set  of 
funded actions in line with the strategic focus agreed. 
7.  Support only those initiatives where the appr.oach taken is 
supported by scientific evidence appropriate to the initiative 
and its context. 
8.  Promote  action-oriented R&D  with a strong emphasis on 
'evidence-based  public  health',  and  promote  more 
systematic  analysis  of theoretical  frames,  research  and 
experiences  in  the  various  key  domains  of  cancer 
prevention. 
9.  Continue  to  support  more  effectively  the  fight  against 
tobacco and the studies and initiatives in nutrition, with a 
more intersectoral approach. 
2.3.8.  Priorities ofthe Programme: Large Projects. 
10.  Prioritise those projects which have a clear European added 
value  and  can  demonstrate  both  a  partnership  between 
Member States and a concrete contribution to  the Europe 
Against Cancer agenda arising from that partnership. 
11.  Use  multi-member  projects  to  carry  out  epidemiological 
studies too large to be conducted in individual countries or 
where practice in any one country is too homogeneous to 
allow sensitive investigation, and  to further research and 
development in prevention practice. 
12.  Use  multi-member  projects  to  further  changes  in  the 
policies and practices of individual Member States and to 
reach sufficient numbers of people to achieve critical mass 
in  changing  attitudes  or  behaviours  in  the  European 
population. 
13.  Provide  a  multiannual  budget  and  organise  a  systematic 
mid-term  review  by  independent  evaluator(s)  where 
appropriate, as well as a final evaluation. 
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measures  to  reach  and  involve  the  local  actors  and 
population. 
15.  Provide support, possibly in the form of  a 'clearing house', 
for  Member  States  who  feel  disadvantaged  in  respect of 
securing international collaborators. 
2.3.9.  Priorities of  the Programme:  Small Projects. 
16.  Allow  small,  single-site  projects  (equivalent  to  those 
currently costing up to 50,000 ECU), only where these are 
highly innovative and have a clear role as European pilot 
schemes likely to demonstrate best practice 
17.  Require such projects to make detailed provision from the 
outset for an optimal dissemination of  results. 
18.  Develop separate reporting requirements for small projects 
so as to minimise bureaucracy and speed up the release of 
funds. 
2.3.10.  Management of  the Programme. 
19.  Agree  explicit programme  goals  for  the  Action Plan and 
review progress towards these goals on a biannual basis. 
20.  Define  intermediate  objectives,  processes  and  as  far  as 
possible outcomes, in order to contribute to more targeted 
applications and selection of  projects. 
21.  Involve independent experts (i.e. experts deemed ineligible 
to receive funding) in the selection process. 
22.  Secure  appropriate  national·  inputs  to  guide  decision-
making  as  regards  both  priorities  and  awards  made  in 
Member States. 
23.  Provide  better access  to  information  concerning calls  for 
tender (wider dissemination and permanent availability on 
the Web). 
24.  Revise the application and selection process to make clear 
the  percentage  of co-financing  needed,  the  number  of 
partners  from  other  Member  States  required  in  various 
circumstances, and the criteria for allowing variations in the 
grant awarding process. 
25.  Standardise application procedures (fonns, deadlines, etc.), 
which has indeed started to  occur recently.  Forms should 
include  such  items  as:  definition of needs,  description of 
objectives, theoretical framework,  methodology, definition 
of activities,  identification of target population, sampling, 
treatment  and  analysis  plan  and  methods,  evaluation 
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for  exploiting  project  results,  type  of report  expected, 
duration/geographical extent of  the project, etc. 
26.  Develop mechanisms permitting a more proactive response 
from the EC when there are not enough projects of quality 
in an area. 
27.  Use  database  software to keep  track of projects,  classify 
them by domain and keywords, and be able to present them 
to the public, via the Programme's INTERNET website, for 
instance. 
28.  Fund  projects  for  a  three  to  five  year  period  where  the 
project objectives cannot realistically be achieved within a 
shorter time scale, on condition that the projects complete a 
sat~sfactory interim review. 
29.  Require  all  projects  applying  for  funds  for  a  period  in 
excess of three years,  and which have  a  logical  lifetime 
beyond the funding period eligible for European support, to 
set out clear proposals for replacing EAC support at their 
mid-term review. 
30.  Consider the possibility of providing ongoing core funding 
for projects with a central role in EAC and with a marked 
European perspective.  · 
2.3.11.  Evaluation of  the Programme. 
31.  Build into the application and grant awarding process the 
specification of  clear milestones against which projects can 
be evaluated. 
32.  Record information on all proposals submitted and rejected, 
in sufficient detail to identifythe proposers, the content of 
the proposal and the reasons for rejection. 
33.  Record  information on all  projects funded,  using a  more 
detailed  format  that  is  consistent  year  on  year  and  that 
identifies  those  projects  in  receipt  of  funding  for  a 
second/third year, the institution and head of  department in 
which the grant is to be held, the nature of the work to be 
carried out and the milestones against which progress is to 
be measured. 
34.  Make  all  national  bodies/charities  applying  for  funds 
specify where within the country the actual  project work 
will take place, and record this clearly. 
35.  Evaluate all projects against the stated milestones and the 
criteria of efficiency, effectiveness and scientific validity, 
using external independent assessors. 
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effectiveness  and  recommendations  are  widely 
disseminated, or at least classified and indexed in some of 
the  available  databases.  The  present  sheet  for  individual 
project assessment could be used for the  presentation. The 
new  European  Thesaurus  on  Health  Promotion  could  be 
used for the classification. The reports and their conclusions 
could also be put on the EC's website and then made easy 
to use by new project managers to enhance their work and 
actions. 
37.  Plan  external  evaluations  of  the  Programme  at  the 
beginning of it rather than at the end, as has been the case, 
and define indicators for process and result evaluation. 
2.3.12.  Future ofthe Programme. 
38.  It  is  vital  to  continue funding  the  EAC  beyond the  Third 
Action Plan, incorporating all the above recommendations. 
The effects of the  EAC  on tobaccoconsumption, diet  and 
nutrition, as well as changes in professional practices with 
regard  to  cancer  prevention,  will  require  more  than  a 
decade  of sustained  effort  in  order  to  have  an  enduring 
impact. 
3.  COMMENTS OF THE COMMISSION 
3.1.  It is particularly reassuring to note that the first conclusion of the evaluation 
made  by  this  independent  body  stresses  that  the  recommendations  of the 
evaluation of the  First Action Plan were  indeed  taken  into ·  account in the 
implementation of  the Second Action Plan. 
3.2.  The evaluation of this  Second  Plan appears very positive overall;  the  few 
areas criticised had been identified during the running of the Programme and 
constant improvements were undertaken to remedy them. 
3.3.  The text of Decision N° 646/96/EC of the  European Parliament and of the 
Council of 29 March 1996 adopting the Third Action Plan to combat cancer 
within  the  framework  of action  in  the  field  of public  health  (1996-2000) 
anticipates  the  conclusions  of this  evaluation  of the  Second  Plan  and  is 
already  contributing  towards  the  positive  evolution  of the  Public  health 
Programmes. 
3.4.  Indeed,  the  Decision  lays  down,  in  particular  in  its  Article  5,  a  series  of 
measures concerning: an annual work programme indicating the priorities for 
action (Art.5b);  simplification and improvement of the  basic administrative 
procedures  (Art.5c);  methods,  criteria and  procedures  for  the  selection  of 
projects  (Art.5d);  the  evaluation  procedure  (Art.5e);  the  methods  of 
distribution  and  transfer  of results  (Art.5f).  Most  of these  measures  have 
already beerr, or are in the process of  being, adopted by the Commission. 
3.5.  In the area of scientific expertise, projects are evaluated by a Committee of 
scientific  experts  nominated  by  the  Member  States.  The  Commission's 
11 financing  proposals  are  therefore  supported  scientifically  and  meet  more 
precisely the identified health needs. 
3.6.  In the areas of screening, smoking prevention and nutrition, the Programme 
initiated the pooling-together of national projects in the form of European-
wide networks such as "ENSP - European Network for Smoking Prevention" 
or "Epic  - European Prospective  Investigation  into  Cancer and  Nutrition", 
thus  avoiding  wide  dispersion  of small  amounts  of funding  and  reducing 
duplication of  work. 
3. 7.  This  pooling  strategy  and  the  need  for  a  European  dimension  is  being 
continued as other important networks are in the process of being developed, 
for example in the field of  palliative care. 
3.8.  In  the  field  of training,  the  Programme  supports various projects targeting 
health professionals (specialists, general practitioners, dentists, nurses, etc). 
3.9.  The organisation of major media events such as the European Weeks brings 
together the  experience of the  national  Leagues  and  Associations  and  the 
specialised media expertise of  a professional communications firm. 
3.1 0.  The  concern raised  in  the evaluation with regard to the transfer of project 
results has become a principal criterion for their financing.  This criterion is 
also present in all the other Programme actions (for example in the evaluation 
of  the European Weeks). 
3.11.  Finally, the Third Action Plan now features  an evaluation process from the 
beginning of  the Programme and, in particular, an evaluation at the half-way 
stage,  allowing  for  rapid  adjustments  to  the  Programme  in  line  with  any 
recommendations issued. 
3  .12.  The evaluation of  the Third Action Plan, which is currently being carried out 
by  same body - ASPHER - , should confirm the  numerous improvements 
made to the "Europe Against Cancer" Programme over recent years. 
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